Post My Press Release

Free Press Release Distribution

Category: Biotechnology (Page 1 of 69)

Fetal Monitoring Market to 2026- Strategies, Applications and Competitive Landscape

Fetal monitoring devices are used to monitor the heart rate and movement of the fetus and maternal contractions. In medical terms, fetal monitoring is imperative to constantly monitor health of the unborn baby and ensure a safe birth. Fetal monitoring measures the heart rate of the baby. Healthcare providers perform fetal monitoring during late pregnancy and labor, as that process is crucial for keeping the mother and the child safe and healthy. These are also used to monitor chronic mental retardation, hypothermia, lung diseases, neonatal diseases, vision & hearing problems, and jaundice.

Fetal monitoring is usually done using handheld doppler device or an electronic fetal monitor. Fetal monitoring is necessary to avoid complications during labor or if patient gets an epidural or if oxytocin is required to induce or augment labor. Moreover there are two ways to perform fetal monitoring namely, external and internal. Fetal monitoring is especially helpful if the patient is expected to have a high-risk pregnancy, especially women suffering from high blood pressure or diabetes.

Download The PDF Brochure:

Increase in birth rate fuels the growth of fetal monitoring market

The boost in fetal monitoring market is due to increased rate of birth and pre-term births. Various government and nongovernment organizations are actively taking initiatives to provide better maternal and fetal care. However, rise in number of problems during pregnancy due to high-blood pressure, diabetes, pre-term labor medicine affect the fetus. So, fetal monitoring device are used routinely by gynecology and obstetrics interventions to examine fetal health during labor and delivery.

Furthermore, advancement in technology such as wireless or real time analysis also expands the market of fetal monitoring devices. The demand of fetal monitoring device is also increased significantly in past few years to reduce intrapartum stillbirths. According to WHO, annually 15 million babies are born pre-term which leads to death. Pre-term babies live only till approx. 5 years of age which is also responsible for nearly 1 million deaths in 2015.

Regional growth engines for fetal monitoring market

Asia Pacific is an emerging region for fetal monitoring market, as healthcare awareness is on the rise in the region and the region is the most populous. However, according to stats mention in World Population Prospects: 2015 Revision, the total fertility was pegged at 2.5 children per woman globally. However, there is wide regional difference across the globe that is further expected to offer irregular scenario over the forecast period in fetal monitoring industry.

Major acquisitions to support growth of fetal monitoring market

Rise in support from government for enhanced maternal facilities such as subsidies given by government to expand care in rural area to private not-for-profit organization, in countries like Uganda as they have poor healthcare facilities. Whereas, the Government of the Philippines has also placed health and maternal health high on its political agenda of reform.

Moreover, rising investment of company for development of new features for fetal monitoring devices expects to increase the working efficiency of company and broadens its product portfolio. Key players in the fetal monitoring market include ArjoHuntleigh, Inc. (U.S.), C FUJIFILM SonoSite, Inc. (U.S.), GE Healthcare (U.K.), Natus Medical Incorporated (U.S.), Neoventa Medical (Sweden), ovidien PLC (U.S.), Philips Healthcare (Netherlands), Siemens Healthcare (Germany), Analogic Corporation (U.S.), and Spacelabs Healthcare Inc. (U.S.).

Click To Read More On Fetal Monitoring Market

Gene Editing Market 2018 By Types, Application, Demand, Services, Players, Growth & Forecast 2025

Rise in funding for genome editing, increase in the occurrence of genetic disorders, growth in the production of genetically modified crops and increase in the developments for the technology of gene editing are the factors driving the growth of gene editing industry. Another major factor expected to fuel the growth of the market includes the rising usage of CRISPR Cas9 technology. On the other hand, strict government rules and lack of awareness among the people for genetic alteration are factors hampering the growth of gene editing market globally.

Request a sample of this report @

The global gene editing market size accounted for USD xx Billion in 2017 and is anticipated to exhibit the growth at a CAGR of x% in terms of revenue and reach USD xx Billion by the end of forecast spell.

Global gene editing market has been segmented by different technology, applications and geography. On the basis of technology, market is divided into Clustered regularly interspaced short palindromic repeats (CRISPR), Transcriptor-activator like effector nuclease (TALEN), Zinc Finger Nucleases (ZFN) and other techniques of gene modification (piggyback transposon, Recombinant adeno-associated virus (rAAV), megatales).

Ethical Implications of Gene Editing

Over the period of next few decades, the technologies related to genome-editing is expected to play a very significant role in terms of human as well as animal health. Presently, a number of genetically engineered strategies of therapeutic other than those from CRISPR has been used in the clinical trials of oncology are on the way of receiving the regulatory authorization. However, it is predictable that a new cohort of therapeutics will ascend, with help of CRISPR technology, because it will allow the analysts to target at the exact genome sequences. This is not possible by other therapeutic modalities. Moreover, genome-editing technologies will mostly benefit the genetic diseases; on the other hand, several non-hereditary pathologies, for instance certain degenerative sicknesses will be obstructed, since many of these sicknesses consists of growing components of genetic mutational because of the epigenetic changes.

Browse the complete report @

The Ongoing Ethical debate

The debate over the genome editing has now been extended to the international level. The clinical recognition of gene-editing tools, including CRISPR, has fostered the ethical as well as legal distresses. Moreover, the misapplication and ethical consequences of the technology over reformed germlines of humans was freshly debated at the International Summit on Human Gene Editing.

Various scientists are encouraging the prohibition or ban for gene editing. Many of the Chinese researchers have worked on the CRISPR editing on monkeys in the year 2014, where CRISPR technology was used for creating the world’s first gene-edited human embryos in 2015 and then in year 2017 used viable human embryos for developing into babies. In the year 2018, in China, He Jiankui, a Chinese researcher of biophysics from the Department of Biology, Southern University of Science and Technology have given birth to discussions and new controversies do not appear to differ easily. He Jiankui states that gene editing was done in the laboratory which results in twin baby girls named Nana and Lulu, where He Jiankui also states that genetic modification will have the potential to attack any infection of human immunodeficiency virus (HIV) in future.

Get the access of more information through our blog, white paper and Case study:

  • White Paper on “CRISPR – A Gateway To An Unimaginable Future!”

CRISPR-Cas9 technology may possibly transform how presently scientists are tackling some of the world’s leading concerns, such as cancer, food scarcities as well as need for organ transplant. It is also being used as an extremely effective syndrome diagnostics instrument. However, alike all other newly invented technologies, CRISPR-Cas9 technology is also bound to show new unpremeditated complications. Altering DNA guidelines will certainly come with significant concerns. Nevertheless, society as well as industry cannot have this discussion with lack of understanding of fundamentals of CRISPR-Cas9 technology. This paper discusses th

Access the complete white paper on Gene Editing market report:

Gene editing is not only a scientific concept, but also an ethical issue for many bioethicists and scientists from around the world. American medical ethicist, Arthur L. Caplan has said that, ‘A moral principle in genetic testing is that it should always be done with the consent of the individual. No one wants someone snooping into his DNA’.  It’s a true statement in all its glory and hence gene editing is an ethical issue for some.  The main concern behind every discussion is that will the changes made in the germline or genetic makeup of a human being be passed on to the future generations. This study focusses on these issues and the challenging technology th

Would you like to access the blog on “Gene Editing Revolutionizing Human Medicine And Agriculture” then Click Here…

About Us:

Adroit Market Research is an India-based business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Info:

Ryan Johnson

Adroit Market Research

3131 McKinney Ave Ste 600,

Dallas, Texas – 75204, U.S.A

Phone No: +1 (214) 884-6068


Global Dental Implants Market Segmentation and Analysis by Recent Trends, Development and Growth by Regions to 2026

Dental implants are implants in the jaw, placed below the gum line, providing a base for planting artificial teeth or bridge. Dental implants market has witnessed drastic rise in the last few years. A number of socioeconomic and technological factors have contributed to overall growth of the industry. Europe and North America account for 65.9% of global dental implants market revenue in 2016. However, market dynamics are expected to witness a major shift, with Asia Pacific and Latin America emerging as the fastest growing markets for dental implant over the forecast period (2016–2024). This is primarily attributed to aging baby boomers population with high spending power. Lately, the industry is witnessing change in market dynamics post-economic recession of 2008. The industry that was once fragmented is slowly shifting towards consolidation. One such example is the acquisition of Astra by DENTSPLY in 2011.

Market Dynamics

With changing market dynamics, companies are emphasizing on product innovation and strengthening of distribution channel to sustain and expand their business reach worldwide. Various macroeconomic factors such as increased geriatric population, growing focus on aesthetics, rise in out-of-pocket spending, and establishment of quality healthcare institutions are expected to bolster sales of dental implant devices worldwide. On an average, over 20% of population in EU is aged over 65 years. Moreover, EU spends nearly 9% of its GDP on healthcare. Increasing consolidation, technological advancement, and company laying emphasis on strengthening distribution channels are some of the key dental implants market trends.

Download the PDF brochure:

Market Taxonomy

This report segments the dental implants market on the basis of product type, technique, population demographics, and end use. On the basis of product type, the market is segmented into titanium and zirconium. On the basis of technique, the dental implants market is segmented as root form and plate form. On the basis of population demographics, the market is segmented into geriatric, middle-aged, adult, and others. On the basis of end-use, the dental implants market is segmented as dental labs, hospitals, and others.

Key features of the study:

This report provides in-depth analysis of the dental implants market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2016 – 2024), considering 2015 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

The report takes into account critical limiting factors such as accuracy issues and need for calibrating the device several times a day while analyzing the market value and growth (%) during the forecast period

It includes insights on population dynamics, number of dental clinic centers, and demand for dental implants across the globe.

Europe is expected to dominate the market throughout the forecast period. The region is expected to account for 30.8% of overall market share by 2024. Competition in dental implants market has increased primarily between Straumann and DENTSPLY Implants. According to Europa, over 25% of the population in Europe is expected to fall under geriatric age group by 2020. This coupled with high discretionary income in the region is expected to continue to position the region as a highly lucrative market for dental implants. Germany is one of the key markets for dental implants. The country spends highest per capita income on teeth than any other country in Europe.

Among product type, titanium dental implants segment is expected to hold dominant position in the dental implants market over the forecast period. The segment accounted for 44.7% of global market revenue in 2015. However, zirconia dental implants segment is expected to hold dominant position in the market by 2024. Key players are launching mini-titanium dental implants solutions, which are compatible with biologically active drugs that are usually incorporated on the surface of implant to improve osseointegration. The consumers mostly prefer titanium dental implants, as it has longer lifespan.

Emerging economies to present highly lucrative growth avenues

Dental implant players are focused towards strengthening of direct distribution channel along with partnership with regional manufacturers and distributors. DENTSPLY Implants, Straumann AG, Bicon Dental Implants, Anthogyr, KYOCERA Medical Corporation, Lifecore Dental Implants, Zest Anchors, Implant Innovations Inc, and BioHorizons IPH, Inc., Neobiotech USA. Inc., Sweden & Martina, TBR Implants Group, Global D, and MOZO-GRAU, S.A. are some of the key industry players in dental implants market.

Click To Read More On Global Dental Implants Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Growth of the Proteomics and Increased Use of Personalized Medicine to Drive Glycobiology Market

According to a new market research report “Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User – Global Forecast to 2021”, published by MarketsandMarkets, the global market is expected to reach USD 1,211.4 Million by 2021 from USD 649.5 Million in 2016, at a CAGR of 13.3% during the forecast period.

Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies are the key drivers for the growth of this market.

Don’t miss out the business opportunities in global Glycobiology Market.

Browse and in-depth TOC on “Glycobiology Market”
91 – Tables
32 – Figures
158 – Pages

Download an Illustrative overview of the report @

The global Glycomics/Glycobiology Market is broadly segmented into product, application, end user, and region. On the basis of product, the market is segmented into enzymes, instruments, kits, and reagents. In 2016, the enzymes segment is expected to account for the largest share of the global Glycomics/Glycobiology Market. The enzymes segment is further categorized into glycosidases, glycosyltransferases, neuraminidases, sialyltransferases, and other enzymes. In 2016, the glycosidases segment is expected to account for the largest share of the market owing to its consumable nature, vast applications of glycosidase enzymes in R&D, and drug development processes.

On the basis of application, the market is segmented into diagnostics, drug discovery and development, immunology, oncology, and other applications. In 2016, the drug discovery and development segment is expected to command the largest share and grow at the highest CAGR during the forecast period. The large share and high growth in this segment can be attributed to the increase in R&D activities for the development of novel drugs and therapies.

On the basis of end user, the market is segmented into academic research institutes, pharmaceutical & biotechnology companies, and contract research organizations. In 2016, the academic research institutes segment is expected to account for the largest share of the market. This growth can be attributed to the rising availability of funding for life science research.

Speak to Subject Expert @

On the basis of region, the market was dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW).

In 2015, North America accounted for the largest share of the market, while Asia witnessed the highest growth rate mainly due to increasing commercialization of pharmaceutical and biotechnology research, increasing awareness about personalized medicine, and rising importance of companion diagnostics.

Major players in the Glycobiology Market include are Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.).

Request Sample Pages @

Saliva Collection Devices Market Positive Long-Term Growth Outlook 2018- 2026

The Global Saliva Collection Devices Market was valued at US$ 1,571.7 million in 2017, and is expected to witness a CAGR of 10.8% over the forecast period (2018 – 2026).

Saliva is the most favored sample of choice in diagnosis due to ease of collection. Salivary biomolecules have provided an aperture in surveying a person’s health and well-being. Saliva contains a myriad of salivary proteins, which could serve as biological markers for diagnosing and tracking the progression of various health conditions, as well as monitoring the effectiveness of medication. Saliva collection devices allow a person to collect resting (unstimulated) saliva or stimulated saliva either via mechanical stimulation or acid stimulation.

Market Dynamics

Rising research activities for saliva collection devices is expected to boost growth of the saliva collection devices in the market. For instance, in July 2017, EquiSal Tapeworm saliva test was launched in the U.S. for detecting tapeworms from saliva of horses. EquiSal saliva collection kits are used for saliva collection, which comprises swabs to be kept in oral cavity of horses.

Furthermore, new marketing strategies by key players are expected to drive growth of the saliva collection devices market over the forecast period. For instance, in October 2018, Mayo Clinic and Helix’s lab launched a solution called, Mayo Clinic GeneGuide. It allows shipment of saliva collection kits to the individual within two days and furthermore, DNA is sequenced for identifying diseases.

Increasing number of saliva collection device approvals is expected to drive growth of the saliva collection devices market

Increase in the number of approvals for saliva collection devices due to its rising need for rapid diagnosis of life threatening diseases is expected to drive growth of the saliva collection devices market. For instance, in February 2015, 23andMe, Inc., received U.S. Food and Drug Administration (USFDA) approval to market the first direct-to-consumer genetic Oragene Dx saliva collection test kits under a regulatory classification for novel devices. The company works with DNA Genotek, a subsidiary of OraSure Technologies, Inc, for Oragene Dx saliva collection kits. Saliva collected by these kits is then used to screen for Bloom Syndrome, a genetic disease.

Furthermore, in January 2015, DNA Genotek Inc., received USFDA approval for Oragene Dx intended for use in the non?invasive collection of saliva samples. DNA from the saliva sample is then isolated, stabilized, and legally marketed for DNA carrier screening genotyping tests.

Moreover, technological advancements for saliva collection of infants are also expected to increase growth of the saliva collection devices market. For instance, Oasis Diagnostics, developed Pedia SAL collection kit for infants. It allows saliva collection process with simplest design intended to not only collect saliva samples but also relax infants during procedure. Saliva can then be expressed from the collector using a compression tube directly into any of a variety of common laboratory vials.

Saliva Collection Devices Market- Competitive Landscape

Key players operating in the saliva collection devices market include Quest Diagnostics, Neogen Corporation, AboGen, Inc., OraSure Technologies, Inc., Oasis Diagnostics Corporation, Alere, Porex Corporation., and Salimetrics, LLC.

Ask For Sample Copy Of This Business Research Report :

Saliva Collection Devices Market- Regional Analysis

Regional segmentation of the global saliva collection devices market comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America held the major share in the global saliva collection devices market during the forecast period, owing to increasing number of new and innovative product launches in the U.S. For instance, in June 2016, DNA Genotek launched saliva sample collection device ORAcollectDx, an alternative to buccal swabs. The device, ORAcollectDx, is part of saliva-based DNA collection and stabilization devices.

Asia Pacific is expected to witness the fastest growth in the global saliva collection devices market the forecast period, due to increasing awareness for safe and easy diagnosis of various diseases through number of symposiums and conferences organized in the region. For instance, in October 2016, Saliva Technology Application Research Symposium was held by Queensland University of Technology, in Australia. The conference highlighted emerging research, translational and technological advances such as saliva biomarker development, innovative saliva collection devices, improving saliva stability and transportation, rapid disease identification, saliva rheology, and many more.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel: +1-206-701-6702

Interventional Cardiology Devices Market: Growth, Development, Trends, Demand, Share, Analysis and Forecast 2026

Interventional cardiology is the branch of cardiology that specifically deals with catheter based treatment of heart diseases, such as congenital heart defect (CHD), coronary artery disease, and aneurysm. This involves insertion of the catheter into femoral artery or any large peripheral artery or vein and through catheter whole procedure is performed by using fluoroscopy. Interventional cardiology has reduced the complications for patients as it provides, fast recovery, short hospital stay, and controlled bleeding. There is constant development in interventional cardiology devices, such as from bare metal stent to bio-absorbable stent. According to Centers for Disease Control and Prevention, which provides information about various diseases, there were around 40,000 children born with CHD in the U.S. in 2016. Interventional cardiology devices include catheters, guide wire, stents, filters, and balloons.

Request For A Sample Copy Of This Research Report:

Interventional cardiology devices market taxonomy:

By Product Type

  • Stents
  • Catheters
  • Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
  • Intravascular Ultrasound System
  • Inferior Vena Cava (IVC) Filter
  • Percutaneous Transluminal Coronary Angiography (PTCA) Guide Wires
  • Left atrial Appendage (LAA) Device

By Geography

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

Increased prevalence of cardiovascular diseases is expected to fuel the growth of interventional cardiology devices market

There is a continuous increase in geriatric population and obesity which is leading  to the increase in cardiovascular disease. For instance, as per United Nations report, there were around 901 million people of age 60 and above in 2015 and it is expected to reach 1.4 billion by 2050. Advancement in healthcare research, increasing patient awareness, and increase in the demand for minimal invasive surgery raise the demand for interventional cardiology devices. Interventional cardiology devices help interventional cardiologist to perform the procedure in short span of time, which reduces the risk and complication. The increase in obesity, geriatric population and lifestyle changes leads to the increase in coronary artery disease, for instance as per American Heart Association 2017 report, in the U.S. there was around 360,000 death caused due to coronary artery disease. With the prevalence of lifestyle diseases such as diabetes and hypertension has increased the cases of cardiovascular disorders.

Developed regions support the growth of interventional cardiology devices market

Interventional cardiology devices market is segmented into various geographical regions such as North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America leads the interventional cardiology devices market because of the large geriatric population and sedentary lifestyle leading to cardiovascular disorders. According to Population Reference Bureau 2016, there were around 40 million people of age 60 and above, and it is expected to reach 89 million by 2050 in the U.S. Europe is closely following the North America in interventional cardiology devices market followed by Asia Pacific. However, Asia Pacific is expected to expand significantly in near future because of emerging economies such as India and China due to the increase in cardiovascular diseases, increased healthcare expenditure, per capita income of individual and increase in geriatric population, which is expected to support the growth of interventional cardiology devices market.

Key players to support the interventional cardiology devices market

There are various players present across the globe contributing to the interventional cardiology devices market. Some key players are Abbott, Terumo Medical Corporation, Boston Scientific Corporation, Cardinal Health, Medtronic, Cook Medical and B. Braun Melsungen AG. In 2017, Abbott acquired St Jude Medicals to increase the product pipeline, as St Jude Medicals are into atrial fibrillation, structural heart, heart failure and chronic pain and Abbott are leading in coronary inventions, which increase the market share and fuels the growth of interventional cardiology devices market.

Click To Read More On Interventional Cardiology Devices Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Genome Engineering Market to Perceive Substantial Growth During 2018–2026

The Global Genome Engineering Market was valued at US$ 2,582.7 Mn in 2016 and is expected to witness a CAGR of 14.3% over the forecast period (2017–2025).

Genome engineering is a technique in which a DNA is inserted, deleted, modified or replaced in the genome of a living organism. Research and development activities are conducted in genome engineering for the development of novel technologies. For instance, in 2017, Synthego Corporation launched a CRISPR Pioneers Program to expand genome engineering research. Researchers are majorly focusing on developing treatments for cancer and rare diseases with the help of genome engineering tools such as CRISPER. Many genome technologies are under trial for treatment of such diseases, and are expected to receive approvals in the near future.

Market Dynamics

Development of novel technologies in genome engineering field is expected to significantly drive growth of the global genome engineering market in the near future. For instance, in 2017, Merck KGaA— Germany-based company—developed a new genome editing tool dubbed ‘proxy-CRISPR’, providing access to previously inaccessible microenvironments of the genome by modification of chromatin modifications. In 2017, Benson Hill Biosystems, Inc.—an agricultural technology company—launched its latest CRISPR 3.0, to increase innovators’ access to gene editing. CRISPR 3.0 is a latest innovative genomics tool, which is expected to improve crop performance. Development of such novel technologies by major key players is expected to create a conducive environment for growth of market.

Increasing development of novel technologies in genome engineering is expected to drive growth of the global genome engineering market in the near future

Key players in the market are focusing on developing novel technologies and launching new products for genome engineering, in order to increase their market share. For instance, in February 2018, Sangamo Therapeutics, Inc. received clinical trial authorization (CTA) from Medicines and Healthcare Products Regulatory Agency (MHRA) in the U.K. for its SB-FIX, a zinc finger nuclease (ZFN)-mediated in-vivo genome editing treatment for hemophilia B. CTA has allowed for the beginning of Europe’s first in-vivo genome editing study. In 2017, Integrated DNA Technologies, Inc. launched the first Cas9 enzyme variant, which reduces off-target effects in CRISPR genome editing.

The launch of latest Cas9 enzyme variant is a major step towards therapeutic use of CRISPR. In 2017, Scientists at Salk Institute for Biological Studies, modified CRISPR to epigenetically treat diabetes, kidney disease, and muscular dystrophy. They developed a latest version of CRISPR/Cas9 genome editing technology, which allows for activation of genes without creating breaks in the DNA. The development of such novel technologies is expected to be major driving factor for growth of global genome engineering market.

Ask For Sample Copy Of This Business Research Report :

Increasing strategic collaboration for genome engineering technologies by key players is expected to drive market growth in the near future

Players in the market are focusing on strategic collaborations, in order to increase their product offerings. For instance, in February 2018, Kite Pharma, Inc.—a Gilead Sciences, Inc. company— collaborated with Sangamo Therapeutics Inc. for developing engineered cell therapies to treat cancer. As per the agreement, Kite Pharma, Inc. will use Sangamo Therapeutics’ zinc finger nuclease (ZFN) gene-editing technology for developing next-generation ex vivo cell therapies for treatment of cancer. Furthermore, in 2017, Synthego and Thermo Fisher Scientific collaborated to manufacture and distribute synthetic guide RNA products for CRISPR genome engineering. In 2016, CRISPR Therapeutics and Bayer AG collaborated and formed a joint venture Casebia Therapeutics, for developing CRISPR-based therapeutics in select disease areas. Moreover, in 2017, Casebia Therapeutics collaborated with CureVac AG.

Competitive Landscape

Key players operating in the genome engineering market include Thermo Fisher Scientific Inc., CRISPR Therapeutics AG, Intellia Therapeutics, Inc., Editas Medicine, Inc., Sangamo Therapeutics, Inc., Bluebird Bio, Inc., Cellectis S.A., and Merck Group.

Moreover, increasing funding and investments for the development and research of new genetic engineering technologies is also expected to drive market growth. For instance, in January 2018, the U.S. National Institutes of Health (NIH) announced to grant US$ 190 million for genome editing research. This new program, Somatic Cell Genome Editing, will award funds to biomedical researchers over the following six years. The support from major research organizations such as NIH is expected to attract more researchers in this field, which may lead to advancements in technology and also aid in growth of the market.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel: +1-206-701-6702

3d cell culture market

3D Cell Culture Market is Projected to Grow at a CAGR of 20.3% | Know the Key Factors

According to a new market research report “3D Cell Culture Market by Product (Scaffold-free (Hanging Drop, Bioreactor), Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell Research, Drug Discovery), End User (Pharmaceutical, Biotech, Research) – Global Forecast to 2022“, published by MarketsandMarkets™, the 3D Cell Culture Market is expected to reach USD 1,720.3 Million by 2022 from USD 682.8 Million in 2017, at a CAGR of 20.3%.

The growth of the market is attributed to the rising focus on developing alternative methods for animal testing, funding initiatives from government and private investors, technological advancements and product launches, and growing awareness.

Speak to Subject Expert @

Scaffold-based 3D cell culture products expected to dominate the market in 2017.

Based on product, the 3D cell culture market is segmented into scaffold-based 3D cell culture, scaffold-free 3D cell culture, microfluidics-based 3D cell culture, and magnetic levitation and 3D bioprinting. In 2017, the scaffold-based 3D cell culture products segment is expected to account for the largest share of the 3D cell culture market. The high growth in this segment is attributed to the ability of scaffold-based products to mimic in vivo conditions, thus driving their adoption among end users.

Browse and in-depth TOC on “3D Cell Culture Market”
111 – Tables
35 – Figures
140 – Pages

Don’t miss out on business opportunities in 3D Cell Culture Market.

Download an Illustrative overview of the report @

North America to dominate the 3D cell culture market

In 2017, North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to factors such as increasing incidence of cancer, presence of a well-established pharmaceutical and biotechnology industry, significant support from the government in the form of funds and grants, availability of technologically advanced products, and presence of key market players.

The 3D cell culture market is highly competitive with the presence of several small and big players. Some of the players in the 3D cell culture market include Thermo Fisher (US), Corning (US), Lonza (Switzerland), Merck (Germany), ReproCELL (Japan), and InSphero (Switzerland). The other players operating in this market include Global Cell Solutions (US), Synthecon (US), 3D Biotek (US), Kuraray (Japan), Hamilton Company (US), Mimetas (Netherlands), Emulate (US), Nano3D Biosciences (US), and QGel (Switzerland).

Request Sample Pages @

Page 1 of 69

Powered by WordPress & Theme by Anders Norén